Open Access

PGM2 overexpression improves anaerobic galactose fermentation in Saccharomyces cerevisiae

  • Rosa Garcia Sanchez1,
  • Bärbel Hahn-Hägerdal1 and
  • Marie F Gorwa-Grauslund1Email author
Microbial Cell Factories20109:40

https://doi.org/10.1186/1475-2859-9-40

Received: 4 March 2010

Accepted: 27 May 2010

Published: 27 May 2010

Abstract

Background

In Saccharomyces cerevisiae galactose is initially metabolized through the Leloir pathway after which glucose 6-phosphate enters glycolysis. Galactose is controlled both by glucose repression and by galactose induction. The gene PGM2 encodes the last enzyme of the Leloir pathway, phosphoglucomutase 2 (Pgm2p), which catalyses the reversible conversion of glucose 1-phosphate to glucose 6-phosphate. Overexpression of PGM2 has previously been shown to enhance aerobic growth of S. cerevisiae in galactose medium.

Results

In the present study we show that overexpression of PGM2 under control of the HXT7' promoter from an integrative plasmid increased the PGM activity 5 to 6 times, which significantly reduced the lag phase of glucose-pregrown cells in an anaerobic galactose culture. PGM2 overexpression also increased the anaerobic specific growth rate whereas ethanol production was less influenced. When PGM2 was overexpressed from a multicopy plasmid instead, the PGM activity increased almost 32 times. However, this increase of PGM activity did not further improve aerobic galactose fermentation as compared to the strain carrying PGM2 on the integrative plasmid.

Conclusion

PGM2 overexpression in S. cerevisiae from an integrative plasmid is sufficient to reduce the lag phase and to enhance the growth rate in anaerobic galactose fermentation, which results in an overall decrease in fermentation duration. This observation is of particular importance for the future development of stable industrial strains with enhanced PGM activity.

Background

Sustainable bioconversion of renewable lignocellulose raw material requires that all sugar components are efficiently utilized [1]. These raw materials are composed of a number of different monosaccharides one of which is galactose. It may constitute up to 18% of the total released monomeric sugar of pretreated softwood [2]. Actually the amount of galactose is higher than that of arabinose in certain raw materials such as willow [3] and spruce [4]. Galactose also makes up a substantial amount of other industrial media raw materials as beet molasses [5] and cheese whey [6].

Baker's yeast, which is the preferred organism for industrial ethanolic fermentation [7], catabolizes galactose via the Leloir pathway [8]. Galactose catabolism to the glycolytic intermediate glucose 6-phosphate is a complex sequence of reactions including phosphorylation and group transfer. Galactose is consumed and metabolized at a significantly lower rate than glucose since it delays induction of glycolytic genes [9]. In addition the Leloir pathway is controlled by glucose repression even in the presence of galactose [10].

When the structural genes for the galactose metabolizing enzymes were overexpressed, growth on galactose was impaired [11]. However increased galactose utilization and ethanol production was observed when genes encoding the galactose regulatory network were engineered [12]. A transcriptome analysis of two of these engineered S. cerevisiae strains, SO7 (pGAL4, 2 μ) and SO16 (Δgal6 Δgal80 Δmig1), later identified a slight up-regulation of PGM2 (GAL5) to be a common denominator [13]. It was also verified that overexpression of PGM2 in S. cerevisiae improved galactose uptake under aerobic conditions while anaerobic conditions were not investigated [13].

The objective of the current study was to investigate the influence of overexpressing PGM2 in S. cerevisiae under anaerobic conditions. PGM2 was expressed both from a multicopy plasmid and from an integrative plasmid. The PGM activity increased 5 to 6-fold in galactose-grown cells when the gene was expressed from the integrative plasmid. PGM2 overexpression reduced the lag phase of glucose pre-grown cells and increased the maximum specific growth rate on galactose. The additional increase of PGM activity in strains expressing PGM2 from a multicopy plasmid did not further increase growth on galactose.

Results

Effect of PGM2 gene dosage

Two strains with different copy numbers of the gene PGM2 were constructed in the same genetic background (Table 1). In both strains, PGM2 was expressed under the control of the constitutive promoter HXT7'[14]. One strain expressed at least one additional integrated copy of PGM2 and was named PGM2 i. Its corresponding control strain was Control i. The other constructed strain overexpressed PGM2 from a multicopy plasmid and was named PGM2 m. Its control strain Control m carried the same plasmid without the structural gene.
Table 1

Plasmids and S. cerevisiae strains used in this study

 

Relevant genotype/phenotype

Reference

Plasmids

  

YEplacHXT

YEplac195, HXT7p-PGKt URA3

[27]

YEplacHXT-PGM2

YEplac195, HXT7p-PGM2-PGKt URA3

This work

YDp-H

HIS3

[33]

YIplac211

URA3

[30]

YIplac211 HXT-PGM2

Ylpac211, HXT7p-PGM2-PGKt URA3

This work

S. cerevisiae strains (*)

  

CEN.PK 113-11C

MAT a his3Δ1 ura 3-52 MAL2-8c SUC2

[28]

TMB 3126

CEN.PK 113-11C, his3Δ1 YEplacHXT URA3

This work

TMB 3400

genomic S. cerevisiae DNA (used as template to amplify PGM2)

[29]

TMB 3127

CEN.PK 113-11C, his3Δ1 YEplacHXT-PGM2 URA3

This work

TMB 3128 "Control m"

TMB 3126 his3::HIS3 YEplacHXT URA3

This work

TMB 3129 "PGM2 m"

TMB 3127 his3::HIS3 YEplacHXT-PGM2 URA3

This work

TMB 3134

CEN.PK 113-11C, his3::HIS3 ura3

This work

TMB 3135 "Control i"

CEN.PK 113-11C, his3::HIS3 ura3::URA3

This work

TMB 3136 "PGM2 i"

CEN.PK 113-11C, his3::HIS3 ura3::URA3 HXT7'p-PGM2-PGKt

This work

(*) Abbreviations of the most important genetic features are shown in quotation marks

The effect of the PGM2 copy number on the specific PGM activity was assessed in crude extracts of cells grown on galactose (Table 2). Strains Control m and Control i displayed the same specific PGM activity, 0.33 and 0.34 U mg-1 protein, respectively, whereas the specific activity in the PGM2 m and PGM2 i strains increased to 10.40 and 1.81 U mg-1 protein, respectively. Whereas PGM activity increased almost 32 fold in the multicopy strain, only a 17 fold increase was observed in the previously reported overexpression of PGM2 on multicopy vector [13] (Table 2). The difference may be ascribed to different strain background, different multicopy vector and different promoter.
Table 2

Specific PGM activity (U mg protein-1) and maximum specific growth rates on galactose

Strain

PGM activity

(U mg protein-1)

Maximum specific growth rates

(h-1)

Control m

0.33 ± 0.03

0.22 ± 0.01

PGM2 m

10.40 ± 1.58

0.30 ± 0.02

Control i

0.34 ± 0.01

0.24 ± 0.02

PGM2 i

1.81 ± 0.47

0.32 ± 0.01

Reference strain[13]

0.14 ± 0.02

0.17 ± 0.01

CB2 strain (pPMA1'p PGM2 2 μ)[13]

2.38

0.23 ± 0.02

Specific PGM activity was measured in extracts of cells grown in defined medium containing galactose (20 g l-1). Specific growth rates (μmax ± standard deviation) were measured under aerobic conditions in defined medium with 50 g l-1 galactose. For comparison, data reprocessed from Bro et al [13] are also reported.

Next, the PGM2 overexpressing strains and their respective control strains were compared with respect to aerobic growth in galactose medium (Table 2, Figure 1). In aerobiosis on galactose, growth, galactose consumption and ethanol production were similar for the two control strains, Control m and Control i (Figure 1). Also the strains overexpressing PGM2, from a multicopy plasmid, PGM2 m, and from an integrated plasmid, PGM2 i, respectively, displayed similar results (Figure 1). The maximum specific growth rates (μmax) were 0.22 ± 0.01 and 0.24 ± 0.02 h-1 for strains Control m and Control i respectively, whereas μmax for strains PGM2 m and PGM2 i increased to 0.30 ± 0.02 and 0.32 ± 0.01 h-1, respectively. Despite the fact that strain PGM2 m had 5 to 6 times higher PGM activity than strain PGM2 i when grown in galactose, μmax did not increase significantly. It was therefore decided to further investigate the influence of increased PGM activity only for strain PGM2 i and its control strain Control i. Additionally the fact that the extra-copy of PGM2 was stably integrated in the genome of the PGM2 i strain enabled us to study the effect of PGM2 overexpression independently of variations in plasmid copy number.
Figure 1

Effect of PGM level on aerobic growth on galactose. Aerobic batch with YNB medium supplemented with 50 g l-1 galactose. Inocula pre-grown on YNB medium with 20 g l-1 glucose. Experiments were performed in duplicate. (A) Biomass formation (OD 620 nm). (B) Galactose consumption. (C) Ethanol production. S. cerevisiae strains: Control m (filled square), PGM2 m (open square), Control i (filled triangle) and PGM2 i (open triangle).

When the strains Control i and PGM2 i were grown aerobically in glucose medium μmax was 0.36 ± 0.01 h-1 and 0.37 ± 0.04 h-1, respectively, which showed that the additional copy of the PGM2 gene did not affect growth on glucose. Assuming that the maximum specific growth rate on glucose (0.37 h-1) is also the theoretical maximum specific growth rate on galactose, overexpression of PGM2 results in a significant contribution to obtaining that growth rate.

Anaerobic fermentation of galactose

Anaerobic fermentation of galactose with the strains Control i and PGM2 i, showed that overexpressing PGM2 reduced the time required to deplete galactose with about 24 h ± 1 h (Figure 2A and 2B). The increased PGM activity consistently reduced the lag phase of fermentative galactose-grown cells (pre-cultivated on glucose) (Figure 2). This was accompanied by an increase of the maximum specific growth rate from 0.098 h-1 ± 0.003 to 0.139 h-1 ± 0.004 (p-value < 0.01) (Table 3). The ratio between the different products of galactose was much less influenced by the increased PGM activity. The ethanol yield was the same for strains Control i and PGM2 i. However, the reduced lag phase and the increased maximum specific growth rate translated into a shorter fermentation duration from 69.3 ± 0.8 h in the Control i strain to 45.5 ± 0.4 in the PGM2 i strain.
Table 3

Parameters analyzed during anaerobic batch fermentation of galactose.

Strain

Maximum specific growth rate μmax

(h-1) a

Biomass yield

(g g galactose -1)

Glycerol yield

(g g galactose-1)

Ethanol yield

(g g galactose -1)

Fermentation time

(h)

Control i

0.098 ± 0.003

0.08 ± 0.00

0.07 ± 0.01

0.41 ±0.02

69.3 ± 0.8

PGM2 i

0.139 ± 0.004

0.09 ± 0.01

0.09 ± 0.01

0.41 ± 0.02

45.5 ± 0.4

aMaximum specific growth rate was calculated by linear regression of a logarithmic plot on the phase of constant and maximum values.

Figure 2

Effect of PGM2 overexpression on anaerobic batch fermentation of galactose. Sugar consumption and product formation in anaerobic batch fermentation of 20 g l-1 galactose in defined medium with strains (A) Control i and (B) PGM2 i. Cells for inocula were pre-grown in defined medium with 20 g l-1 glucose. Experiments were performed in duplicate. Symbols: galactose (filled square), ethanol (filled triangle), biomass (DW) (open circle), glycerol (cross symbol).

Discussion

The present study demonstrates for the first time that the introduction in the chromosome of an additional copy of the gene PGM2 encoding Pgm2p under the control of a strong and constitutive promoter increased the maximum specific growth rate on galactose in anaerobic fermentation. In addition the lag phase of glucose-pregrown cells in anaerobic galactose medium was significantly reduced. The extra integrated copy of the gene PGM2 increased the PGM activity 5 to 6 times in galactose-grown cells. Further overexpression of PGM2 from a multicopy plasmid increased the PGM activity almost 32 times as compared to the control strain but this did not further increase aerobic growth on galactose compared with overexpression from an extra chromosomal copy.

Pgm2p catalyses the last step in the Leloir pathway [8] where glucose 1-phosphate (G1P) is reversibly converted to the glycolytic intermediate glucose 6-phosphate (G6P). Pgm2p is the major isoform of the PGM enzyme in S. cerevisiae accounting for 80 to 90% of the PGM activity [15, 16]. Pgm2p was originally believed to be constitutively present in high levels [10, 15]. However, it was later found that the exposure to galactose gives lower induction of Pgm2p activity compared to other structural GAL genes that are at least 1000-fold induced [10, 16]. The fact that overexpression of PGM2 under a strong constitutive promoter enhanced growth on galactose indicates that PGM is a controlling enzyme in the Leloir pathway.

Overexpression of PGM2 has previously been shown to increase the galactose uptake rate and the specific growth rate under aerobic conditions [13]. In the current study we confirmed these results in another strain background. When compared with the results of Bro et al, higher specific growth rates on galactose were obtained for both the control strains and the PGM2 overexpressing strains under aerobiosis. However higher concentrations of galactose were used in the present study. Nevertheless, in both studies the aerobic specific growth rates on galactose increased by 33-36% when the overexpressing PGM2 gene was overexpressed. We also found that, in our strain background, the increased PGM activity brought the aerobic specific growth rate in 50 g l-1 galactose medium, 0.32 h-1, close to that in 20 g l-1 glucose medium, 0.37 h-1.

Absence of anaerobic growth on galactose has been frequently observed for S. cerevisiae[1719] and it has recently been ascribed to low cellular energy charge [18]. In the present study, an increased PGM activity resulted in improved anaerobic galactose utilization, which indicated that the energy charge deficiency may not be the only limitation of the Leloir pathway. For instance PGM upregulation has been shown to increase the intracellular levels of glucose 6-phosphate [11, 13, 20] that is known to activate glycolysis [9, 21, 22].

Conclusions

Chromosomal integration of an additional copy of the PGM2 gene was sufficient to increase the anaerobic growth rate with 42% and reduce the fermentation time by 34%. Chromosomal integration allows for the construction of stable industrial strains that are expected to decrease the ethanol production time. These results have practical implications for industrial ethanolic fermentation of raw materials containing galactose, such as raffinose from the sugar industry [5], whey from the dairy industry [6] and lignocellulose for fuel ethanol production [24].

Methods

Strains

Escherichia coli DH5α and JM101 (Life Technologies, Rockville, MD, USA) were used for cloning. Plasmids and Saccharomyces cerevisiae strains (Table 1) were stored at -80°C in 15% glycerol. Freshly streaked plates from frozen stocks were used to inoculate pre-cultures.

Molecular biology techniques

Standard molecular biology techniques were used for cloning [23]. Restriction enzymes, T4-DNA ligase and Shrimp Alkaline Phosphatase (SAP) were obtained from Fermentas (Vilnius, Lithuania). Yeast genomic DNA was purified with Easy-DNA Kit (Invitrogen, Groningen, The Netherlands). Escherichia coli DH5α competent cells were prepared as described before [24] and transformed using the calcium chloride method [25]. Yeast was transformed with the lithium acetate method [26]. Plasmids were extracted from bacteria either with GeneJET TM (Fermentas, Vilnius, Lithuania) or with QIAGEN Mini Plasmid Purification kit (Qiagen GmbH, Hilden, Germany). The QIAquick® kit was used for Gel Extraction of DNA fragments from agarose gel as well as for PCR purification of amplified DNA products. Taq-polymerase (Fermentas, Vilnius, Lithuania) was used for analytical PCR, while Pfu-polymerase (Fermentas, Vilnius, Lithuania) and Pwo-polymerase (Roche Diagnostics GmbH, Mannheim, Germany) were used for High-fidelity PCR. Abi-Prism Big-Dye cycle sequencing kit (Applied Biosystems, Weiterstadt, Germany) was used for DNA sequencing that was performed by BM labbet AB (Furulund, Sweden).

Construction of strains expressing multiple copies of the PGM2 gene

The YEplacHXT vector [27] that enables strong constitutive expression under the yeast promoter HXT7'[14] was linearized between the HXT7' promoter and PGK terminator using BamHI and PstI. Transformation of S. cerevisiae CEN.PK 113-11C [28] with the cleaved vector YEplacHXT generated strain TMB 3126 (Table 1). In parallel, the PGM2 gene was amplified from genomic DNA from TMB 3400 (Table 1) [29] using primers with overhangs (in bold) homologous to the 3' region of the HXT7' promoter(5'TTTTTTAATTTTAATCAAAAAAGGATCCCCGGGCTGCA ATGTCATTTCAATTGAAACG-3') and the 5' region of the PGK terminator (5'CCACCACCAGTAGAGACATGGGAGATCTAGAATTCCT TTAAGTACGAACCGTTGG-3'). The amplified fragment and the linearized plasmid were introduced in CEN.PK 113-11C to form the plasmid YEplacHXT-PGM2 by recombination (Table 1) and generated strain TMB 3127 (Table 1). The histidine auxotrophy of strains TMB 3216 and TMB 3127 was complemented by transforming the strains with a linear fragment containing the HIS3 locus that was amplified from YDp-H plasmid (Berben, Dumont et al. 1991) and selecting for growth in defined mineral medium without supplementation. The resulting strains were named Control m and PGM2 m, respectively (Table 1).

Plasmids were rescued and transformed into E. coli DH5α for verification. Analytical PCR of recovered plasmids confirmed that extra copies of PGM2 under the HXT7p' were present in PGM2 m but not in the Control m strain.

Genomic integration of PGM2

The HIS3 amplicon was first transformed into S. cerevisiae CEN.PK 113-11C and transformants were selected on defined mineral medium supplemented with uracil. The resulting strain TMB 3134 (Table 1) was used to construct the strains Control i, TMB 3135 and PGM2 i, TMB 3136 (Table 1) as follows. The purified plasmid YEplacHXT-PGM2 (Table 1) from strain PGM2 m was used as template to PCR amplify the amplicon HXT7'p-PGM2-PGKt using Pwo-polymerase and the following primers: PGKSalI (5' ATCTGTCGACGACATAGAAATATCGAATGG 3') with sequence homologous to PGKt (in bold) and HXTSalI (5' ATCTGTCGACAGGAACAATTTCGGGCC 3') with sequence homologous to HXT7'p (in bold). The PCR product HXT7'p-PGM2-PGKt and the integrative vector YIplac211 [30] were cleaved with restriction enzyme SalI and ligated. The ligation mixture was transformed into E. coli DH5α competent cells and transformants were selected on LB plates with 100 mg l-1 ampicillin. PCR and restriction analyses were used to confirm the proper size of the resulting plasmid YIplac211 HXT-PGM2.

Purified plasmids YIplac211 and YIplac211 HXT-PGM2 (Table 1) from E. coli were cleaved with Eco RV to target the URA3 locus in strain TMB 3134. The prototrophic strain Control i and PGM2 i were generated by integration of cleaved YIplac211 and YIplac211 HXT-PGM2 (Table 1), respectively. Genomic integration of HXT7'p-PGM2-PGKt was verified by analytical PCR of genomic DNA.

Aerobic cultivation conditions

E. coli was grown and selected on Luria-Bertani medium (LB) [23] with 100 mg l-1 ampicillin.

For yeast strains 6.7 g l-1 Yeast Nitrogen Base medium (YNB, Difco Laboratories-Becton, Dickinson and Co., Sparks, MD, USA) was supplemented either with 50 g l-1 galactose or 20 g l-1 glucose as sole carbon source to assess growth. YNB liquid medium was buffered with potassium hydrogen phthalate (10.21 g l-1 phthalate, 2.1 g l-1 KOH, pH 5.5) [31]. For growth on plates 20 g l-1 glucose and 20 g agar l-1 was used. The concentration of YNB was doubled when the sugar concentration was above 20 g l-1 to avoid nutrient limitation. Pre-cultures grown in YNB with 20 g l-1 glucose until mid-late exponential phase overnight in 50 ml tubes were used to inoculate batch cultures at OD 620 nm 0.1-0.2 in cotton-stoppered baffled 500 ml flasks. To ensure initial aerobic conditions, the growth media was only 10% of the flask volume. YNB medium was supplemented with 40 mg l-1 histidine and 20 mg l-1 uracil for auxotrophic strains. Cultivation was performed at 30°C and 180-200 rpm agitation (Gallenkamp INR-200, Leicester, UK) at least in duplicate.

Anaerobic fermentation

For anaerobic fermentation and corresponding pre-cultures defined mineral medium [32] was used. The medium for anaerobic fermentation was supplemented with 0.4 g l-1 Tween 80 and 0.01 g l-1 ergosterol and 20 g l-1 galactose. The pre-culture medium contained 20 g l-1 glucose and was buffered with phthalate buffer (10.21 g l-1 phthalate, 2.1 g l-1 KOH, pH 5.5) [31] whereas the bioreactor pH was controlled at 5.5 with automatic addition of 3 M KOH.

A first pre-culture was grown until late exponential phase in 50 ml tubes. The culture was used to inoculate a second aerobic pre-culture in 1000 ml cotton-stoppered baffled shake flasks. Both pre-cultures were grown in media, constituting 10% of vessel volume to assure maximum aeration. Cultures were grown at 30°C (Gallenkamp INR-200, Leicester, UK) and 180-200 rpm. Cells from the second pre-culture were grown until late exponential phase, washed twice with sterile water, centrifuged at 5000 rpm for 10 min, and used to inoculate anaerobic batch cultures at OD 620 nm of 0.1-0.2.

Anaerobic batch fermentation was performed in 3 l Applikon® Bio Reactors (Applikon, Schiedam, The Netherlands) with a working volume of 1.5 l, at 30°C and 200 rpm stirring. Prior to inoculation the bioreactor was flushed with nitrogen gas containing less than 5 ppm O2 (AGA Gas, Sundbyberg, Sweden) from the bottom of the bioreactor at a flow rate of 0.2 l min-1 controlled by a gas mass flow-meter (Bronkhorst, HI-TECH, Ruurlo, The Netherlands). Outlet carbon dioxide and oxygen were monitored by a Carbon Dioxide and Oxygen Monitor type 1308 (Brüel & Kjaer, Copenhagen, Denmark). Off-gas condensers were cooled to 4°C to minimize ethanol evaporation and a dissolved oxygen probe monitored 0% oxygen tension. Anaerobic fermentation experiments were performed in at least biological duplicates and metabolite measurements varied with less than 10%. Cultivation was performed both with and without nitrogen gas flushing. Flushing resulted in an increased lag phase but did not affect the outcome of the experiment. Physiological characterization of recombinant strains was only performed with the prototrophic strains.

Enzymatic activity measurements

PGM activity was determined in crude extracts of cells grown on YNB medium containing 20 g l-1 galactose. For every strain, at least three independent biological replicates were assayed with at least two independent enzymatic measurements. Cells were harvested in exponential phase, centrifuged at 5000 rpm for 5 min, washed twice with cold sterile water and permeabilized with Y-PER (Pierce, Rockford, IL, USA). The protein concentration was determined with Coomassie Protein Assay Reagent (Pierce, Rockford, IL, USA), using bovine serum albumin as standard. Phosphoglucomutase activity was determined at 30°C by monitoring NAPDH production at 340 nm [13] with a Ultrospec 2100 pro spectrophotometer (Amersham Biosciences, Uppsala, Sweden). The chemicals used to determine enzyme activity were purchased from Sigma-Aldrich (St. Louis, MO, USA).

Determination of metabolites and maximum specific growth rate

Concentrations of galactose, glycerol, acetic acid and ethanol were determined by high-pressure liquid chromatrography (HPLC) (Waters, Milford, MA, USA or Beckman Instruments Fullerton, CA, USA) with an Aminex HPX-87H ion exchange column (Bio-Rad, Hercules, USA) at 45°C. The mobile phase was 5 mM H2SO4 at a flow rate of 0.6 ml min-1. Cell dry weight was determined in at least duplicate at different time points of the fermentation experiment by filtering 5 ml culture through a pre-weighed and microwaved dried hydrophilic polyethersulfone 0.45 μM filter (PALL, Life Sciences, Michigan, USA). The filters were dried at 350 W for 8 min in a microwave oven and cooled prior to weighing.

The maximum specific growth rate was calculated by linear regression on a logarithmic plot of the phase of constant and maximum values.

Declarations

Acknowledgements

The Swedish Energy Agency and the EU project NILE (New Improvements for Ligno-cellulosic Ethanol) financially supported the investigation.

Authors’ Affiliations

(1)
Department of Applied Microbiology, Lund University

References

  1. Sassner P, Galbe M, Zacchi G: Techno-economic evaluation of bioethanol production from three different lignocellulosic materials. Biomass and Bioenergy. 2008, 32 (5): 422-430. 10.1016/j.biombioe.2007.10.014.View ArticleGoogle Scholar
  2. Yu S, Wayman M, Parekh SK: Fermentation to ethanol of pentose-containing spent sulphite liquor. Biotechnology and Bioengineering. 1987, 29 (9): 1144-1150. 10.1002/bit.260290915.View ArticleGoogle Scholar
  3. Sassner P, Galbe M, Zacchi G: Steam pretreatment of salix with and without SO2 impregnation for production of bioethanol. Applied Biochemistry and Biotechnology. 2005, 121-124: 1101-1117. 10.1385/ABAB:124:1-3:1101.View ArticleGoogle Scholar
  4. Söderström J, Pilcher L, Galbe M, Zacchi G: Two-step steam pretreatment of softwood with SO2 impregnation for ethanol production. Applied Biochemistry and Biotechnology. 2002, 98-100: 5-21. 10.1385/ABAB:98-100:1-9:5.View ArticleGoogle Scholar
  5. Gasent-Ramírez JM, Codón AC, Benítez T: Characterization of genetically transformed Sacerevisiae baker's yeasts able to metabolize melibiose. Appl Environ Microb. 1995, 61 (6): 2113-2121.Google Scholar
  6. González Siso MI: The biotechnological utilization of cheese whey: A review. Bioresource Technology. 1996, 57 (1): 1-11. 10.1016/0960-8524(96)00036-3.View ArticleGoogle Scholar
  7. Rudolf A, Karhumaa K, Hahn Hägerdal B: Ethanol production from traditional and emerging raw materials. Yeast Biotechnology: Diversity and Applications. 2009, 3: 489-513. full_text. Springer NetherlandsView ArticleGoogle Scholar
  8. Leloir LF: The enzymatic transformation of uridine diphosphate glucose into a galactose derivative. Archives of Biochemistry and Biophysics. 1951, 33 (2): 186-190. 10.1016/0003-9861(51)90096-3.View ArticleGoogle Scholar
  9. Gonçalves PM, Griffioen G, Bebelman JP, Planta RJ: Signalling pathways leading to transcriptional regulation of genes involved in the activation of glycolysis in yeast. Molecular Microbiology. 1997, 25 (3): 483-493. 10.1046/j.1365-2958.1997.4811847.x.View ArticleGoogle Scholar
  10. Johnston M: A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiological Reviews. 1987, 51 (4): 458-476.Google Scholar
  11. de Jongh WA, Bro C, Ostergaard S, Regenberg B, Olsson L, Nielsen J: The roles of galactitol, galactose-1-phosphate, and phosphoglucomutase in galactose-induced toxicity in Saccharomyces cerevisiae. Biotechnology and Bioengineering. 2008, 101 (2): 317-326. 10.1002/bit.21890.View ArticleGoogle Scholar
  12. Ostergaard S, Olsson L, Johnston M, Nielsen J: Increasing galactose consumption by Saccharomyces cerevisiae through metabolic engineering of the GAL gene regulatory network. Nature Biotechnology. 2000, 18 (12): 1283-1286. 10.1038/82400.View ArticleGoogle Scholar
  13. Bro C, Knudsen S, Regenberg B, Olsson L, Nielsen J: Improvement of galactose uptake in Saccharomyces cerevisiae through overexpression of phosphoglucomutase: example of transcript analysis as a tool in inverse metabolic engineering. Applied and Environmental Microbiology. 2005, 71 (11): 6465-6472. 10.1128/AEM.71.11.6465-6472.2005.View ArticleGoogle Scholar
  14. Hauf J, Zimmermann FK, Muller S: Simultaneous genomic overexpression of seven glycolytic enzymes in the yeast Saccharomyces cerevisiae. Enzyme and Microbial Technology. 2000, 26 (9-10): 688-698. 10.1016/S0141-0229(00)00160-5.View ArticleGoogle Scholar
  15. Bevan P, Douglas HC: Genetic control of phosphoglucomutase variants in Saccharomyces cerevisiae. Journal of Bacteriology. 1969, 98 (2): 532-&.Google Scholar
  16. Oh D, Hopper JE: Transcription of a yeast phosphoglucomutase isozyme gene is galactose inducible and glucose repressible. Molecular and Cellular Biology. 1990, 10 (4): 1415-1422.View ArticleGoogle Scholar
  17. Karhumaa K, Garcia Sanchez R, Hahn-Hägerdal B, Gorwa-Grauslund MF: Comparison of the xylose reductase-xylitol dehydrogenase and the xylose isomerase pathways for xylose fermentation by recombinant Saccharomyces cerevisiae. Microbial Cell Factories. 2007, 6: 5- 10.1186/1475-2859-6-5.View ArticleGoogle Scholar
  18. Brink van den J, Akeroyd M, Hoeven van der R, Pronk JT, de Winde JH, Daran-Lapujade P: Energetic limits to metabolic flexibility: responses of Saccharomyces cerevisiae to glucose-galactose transitions. Microbiology. 2009, 155: 1340-1350. 10.1099/mic.0.025775-0.View ArticleGoogle Scholar
  19. Franco-Duarte R, Umek L, Zupan B, Schuller D: Computational approaches for the genetic and phenotypic characterization of a Saccharomyces cerevisiae wine yeast collection. Yeast. 2009, 26 (12): 675-692. 10.1002/yea.1728.View ArticleGoogle Scholar
  20. Howard SC, Deminoff SJ, Herman PK: Increased phosphoglucomutase activity suppresses the galactose growth defect associated with elevated levels of Ras signaling in S. cerevisiae. Current Genetics. 2006, 49 (1): 1-6. 10.1007/s00294-005-0036-z.View ArticleGoogle Scholar
  21. Boles E, Heinisch J, Zimmermann FK: Different signals control the activation of glycolysis in the yeast Saccharomyces cerevisiae. Yeast. 1993, 9 (7): 761-770. 10.1002/yea.320090710.View ArticleGoogle Scholar
  22. Müller S, Boles E, May M, Zimmermann FK: Different internal metabolites trigger the induction of glycolytic gene-expression in Saccharomyces cerevisiae. Journal of Bacteriology. 1995, 177 (15): 4517-4519.Google Scholar
  23. Sambrook J, Fritch E, T M: Molecular Cloning: A Laboratory Manual. 1989, Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NYGoogle Scholar
  24. Inoue HN, Okayama HH: High efficiency transformation of Escherichia coli with plasmids. Gene. 1990, 96 (1): 23-28. 10.1016/0378-1119(90)90336-P.View ArticleGoogle Scholar
  25. Dagert M, Ehrlich SD: Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene. 1979, 6 (1): 23-28. 10.1016/0378-1119(79)90082-9.View ArticleGoogle Scholar
  26. Gietz RD, Schiestl RH, Willems AR, Woods RA: Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. Yeast. 1995, 11 (4): 355-360. 10.1002/yea.320110408.View ArticleGoogle Scholar
  27. Karhumaa K, Hahn-Hägerdal B, Gorwa-Grauslund MF: Investigation of limiting metabolic steps in the utilization of xylose by recombinant Saccharomyces cerevisiae using metabolic engineering. Yeast. 2005, 22 (5): 359-368. 10.1002/yea.1216.View ArticleGoogle Scholar
  28. Entian K, Kötter P: Yeast mutant and plasmid collections. Yeast gene analysis. Edited by: Brown JPA, Tuite MF. 1998, 26: 431-449. full_text. San Diego California Academic PressView ArticleGoogle Scholar
  29. Wahlbom CF, van Zyl WH, Jonsson LJ, Hahn-Hägerdal B, Otero RR: Generation of the improved recombinant xylose-utilizing Saccharomyces cerevisiae TMB 3400 by random mutagenesis and physiological comparison with Pichia stipitis CBS 6054. FEMS Yeast Research. 2003, 3 (3): 319-326. 10.1016/S1567-1356(02)00206-4.View ArticleGoogle Scholar
  30. Gietz RD, Sugino A: New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene. 1988, 74 (2): 527-534. 10.1016/0378-1119(88)90185-0.View ArticleGoogle Scholar
  31. Hahn-Hägerdal B, Karhumaa K, Larsson CU, Gorwa-Grauslund M, Gorgens J, van Zyl WH: Role of cultivation media in the development of yeast strains for large scale industrial use. Microbial Cell Factories. 2005, 4: 31- 10.1186/1475-2859-4-31.View ArticleGoogle Scholar
  32. Jeppsson M, Bengtsson O, Franke K, Lee H, Hahn-Hägerdal B, Gorwa-Grauslund MF: The expression of a Pichia stipitis xylose reductase mutant with higher K(M) for NADPH increases ethanol production from xylose in recombinant Saccharomyces cerevisiae. Biotechnology and Bioengineering. 2006, 93 (4): 665-673. 10.1002/bit.20737.View ArticleGoogle Scholar
  33. Berben G, Dumont J, Gilliquet V, Bolle PA, Hilger F: The YDp plasmids: a uniform set of vectors bearing versatile gene disruption cassettes for Saccharomyces cerevisiae. Yeast. 1991, 7 (5): 475-477. 10.1002/yea.320070506.View ArticleGoogle Scholar

Copyright

© Sanchez et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement